<?xml version="1.0" encoding="UTF-8"?><!-- generator="wordpress.com" -->
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	>

<channel>
	<title>fundamental-research-and-analysis &amp;laquo; WordPress.com Tag Feed</title>
	<link>http://en.wordpress.com/tag/fundamental-research-and-analysis/</link>
	<description>Feed of posts on WordPress.com tagged "fundamental-research-and-analysis"</description>
	<pubDate>Thu, 20 Jun 2013 01:33:26 +0000</pubDate>

	<generator>http://en.wordpress.com/tags/</generator>
	<language>en</language>

<item>
<title><![CDATA[We are bearish on Meridian Biosciences. Can the molecular diagnostics market propel the stock?]]></title>
<link>http://57thstresearch.wordpress.com/2011/11/28/we-are-bearish-on-meridian-biosciences-can-the-molecular-diagnostics-market-propel-the-stock/</link>
<pubDate>Tue, 29 Nov 2011 03:14:03 +0000</pubDate>
<dc:creator>Digital media and Analytics professional</dc:creator>
<guid>http://57thstresearch.wordpress.com/2011/11/28/we-are-bearish-on-meridian-biosciences-can-the-molecular-diagnostics-market-propel-the-stock/</guid>
<description><![CDATA[Wall Street loves Meridian Biosciences (ticker VIVO) right? Generic Company Teva We are now covering]]></description>
<content:encoded><![CDATA[Wall Street loves Meridian Biosciences (ticker VIVO) right? Generic Company Teva We are now covering]]></content:encoded>
</item>
<item>
<title><![CDATA[Gilead Sciences in bold move pays a 94% premium for Pharmasset. Can you say overpaid!!]]></title>
<link>http://57thstresearch.wordpress.com/2011/11/22/gilead-sciences-in-bold-move-pays-a-94-premium-for-pharmasset-can-you-say-overpaid/</link>
<pubDate>Wed, 23 Nov 2011 02:06:41 +0000</pubDate>
<dc:creator>Digital media and Analytics professional</dc:creator>
<guid>http://57thstresearch.wordpress.com/2011/11/22/gilead-sciences-in-bold-move-pays-a-94-premium-for-pharmasset-can-you-say-overpaid/</guid>
<description><![CDATA[Yes Gilead Sciences Inc. agreed yesterday to buy Pharmasset for $10.8 billion, valuing a DEVELOPER o]]></description>
<content:encoded><![CDATA[Yes Gilead Sciences Inc. agreed yesterday to buy Pharmasset for $10.8 billion, valuing a DEVELOPER o]]></content:encoded>
</item>
<item>
<title><![CDATA[Stalwart Health Care Large Caps need the following characteristics]]></title>
<link>http://57thstresearch.wordpress.com/2011/11/22/stalwart-health-care-large-caps-need-the-following-characteristics/</link>
<pubDate>Tue, 22 Nov 2011 21:52:15 +0000</pubDate>
<dc:creator>Digital media and Analytics professional</dc:creator>
<guid>http://57thstresearch.wordpress.com/2011/11/22/stalwart-health-care-large-caps-need-the-following-characteristics/</guid>
<description><![CDATA[Our mid and large cap pharma 2012 picks have the following market characteristics 1) Predictable Ear]]></description>
<content:encoded><![CDATA[Our mid and large cap pharma 2012 picks have the following market characteristics 1) Predictable Ear]]></content:encoded>
</item>
<item>
<title><![CDATA[Bayer's Glucobay fights to hold onto Chinese Diabetes Drug market estimated to be $2 billion by 2019]]></title>
<link>http://57thstresearch.wordpress.com/2011/11/21/bayers-glucobay-fights-to-hold-onto-chinese-diabetes-drug-market-estimated-to-be-2-billion-by-2019/</link>
<pubDate>Mon, 21 Nov 2011 14:21:19 +0000</pubDate>
<dc:creator>Digital media and Analytics professional</dc:creator>
<guid>http://57thstresearch.wordpress.com/2011/11/21/bayers-glucobay-fights-to-hold-onto-chinese-diabetes-drug-market-estimated-to-be-2-billion-by-2019/</guid>
<description><![CDATA[The Chinese diabetes drug market is looking for more alternatives as it&#8217;s aging population and]]></description>
<content:encoded><![CDATA[The Chinese diabetes drug market is looking for more alternatives as it&#8217;s aging population and]]></content:encoded>
</item>
<item>
<title><![CDATA[Norvartis has upside but patent expirations are a cause of investor concern]]></title>
<link>http://57thstresearch.wordpress.com/2011/11/10/norvartis-has-upside-but-patent-expirations-are-a-cause-of-investor-concern/</link>
<pubDate>Thu, 10 Nov 2011 18:23:57 +0000</pubDate>
<dc:creator>Digital media and Analytics professional</dc:creator>
<guid>http://57thstresearch.wordpress.com/2011/11/10/norvartis-has-upside-but-patent-expirations-are-a-cause-of-investor-concern/</guid>
<description><![CDATA[In on corner we have a 54 Billion dollar diversified pharma juggernaut with 4% dividend yield 147 dr]]></description>
<content:encoded><![CDATA[In on corner we have a 54 Billion dollar diversified pharma juggernaut with 4% dividend yield 147 dr]]></content:encoded>
</item>
<item>
<title><![CDATA[3Q 2011 Forward Earnings of Top Tech Companies now at 12  Cheap?   ]]></title>
<link>http://57thstresearch.wordpress.com/2011/10/27/3q-2011-forward-earnings-of-top-tech-companies-now-at-12-cheap/</link>
<pubDate>Thu, 27 Oct 2011 21:04:38 +0000</pubDate>
<dc:creator>Digital media and Analytics professional</dc:creator>
<guid>http://57thstresearch.wordpress.com/2011/10/27/3q-2011-forward-earnings-of-top-tech-companies-now-at-12-cheap/</guid>
<description><![CDATA[Folks there is a great opportunity now in technology. Here are the broader industries you should be]]></description>
<content:encoded><![CDATA[Folks there is a great opportunity now in technology. Here are the broader industries you should be]]></content:encoded>
</item>
<item>
<title><![CDATA[MELA is finally granted an approval letter by FDA? Now what?]]></title>
<link>http://57thstresearch.wordpress.com/2011/10/03/mela-is-finally-granted-an-approval-letter-by-fda-now-what/</link>
<pubDate>Tue, 04 Oct 2011 03:34:22 +0000</pubDate>
<dc:creator>Digital media and Analytics professional</dc:creator>
<guid>http://57thstresearch.wordpress.com/2011/10/03/mela-is-finally-granted-an-approval-letter-by-fda-now-what/</guid>
<description><![CDATA[MELA finally got an approval letter from the FDA.  Does this mean that the Cancer Diagnostic MELAFIN]]></description>
<content:encoded><![CDATA[MELA finally got an approval letter from the FDA.  Does this mean that the Cancer Diagnostic MELAFIN]]></content:encoded>
</item>
<item>
<title><![CDATA[E-Detailing and Cloud, IPAD are changing  in Pharma , Generics and Biologics. Massive sales reps to be layed off]]></title>
<link>http://57thstresearch.wordpress.com/2011/09/16/e-detailing-and-cloud-ipad-are-changing-in-pharma-generics-and-biologics-massive-sales-reps-to-be-layed-off/</link>
<pubDate>Fri, 16 Sep 2011 17:08:12 +0000</pubDate>
<dc:creator>Digital media and Analytics professional</dc:creator>
<guid>http://57thstresearch.wordpress.com/2011/09/16/e-detailing-and-cloud-ipad-are-changing-in-pharma-generics-and-biologics-massive-sales-reps-to-be-layed-off/</guid>
<description><![CDATA[Gone are the days of the branded and generics direct sales reps.   Teva recently layed off 40% of sp]]></description>
<content:encoded><![CDATA[Gone are the days of the branded and generics direct sales reps.   Teva recently layed off 40% of sp]]></content:encoded>
</item>
<item>
<title><![CDATA[Pfizer (PFE) mulls spinning off nutrition business for $6.8 Billion  Can it grow earnings as it becomes smaller?]]></title>
<link>http://57thstresearch.wordpress.com/2011/03/17/pfizer-pfe-mulls-spinning-off-nutrition-business-for-6-8-billion-can-it-grow-earnings-as-it-becomes-smaller/</link>
<pubDate>Thu, 17 Mar 2011 19:27:26 +0000</pubDate>
<dc:creator>Digital media and Analytics professional</dc:creator>
<guid>http://57thstresearch.wordpress.com/2011/03/17/pfizer-pfe-mulls-spinning-off-nutrition-business-for-6-8-billion-can-it-grow-earnings-as-it-becomes-smaller/</guid>
<description><![CDATA[Pfizer Inc. (PFE) is mulling a spinoff of it&#8217;s nutrition business that could command a price t]]></description>
<content:encoded><![CDATA[Pfizer Inc. (PFE) is mulling a spinoff of it&#8217;s nutrition business that could command a price t]]></content:encoded>
</item>
<item>
<title><![CDATA[Radiation Drug Makers in high demand including Ambex, Fleming, Thyrosafe]]></title>
<link>http://57thstresearch.wordpress.com/2011/03/15/radiation-drug-makers-in-high-demand-including-ambex-fleming-thyrosafe/</link>
<pubDate>Tue, 15 Mar 2011 19:40:23 +0000</pubDate>
<dc:creator>Digital media and Analytics professional</dc:creator>
<guid>http://57thstresearch.wordpress.com/2011/03/15/radiation-drug-makers-in-high-demand-including-ambex-fleming-thyrosafe/</guid>
<description><![CDATA[Nuclear Concerns Prompt Buying. How long will it last? Mounting risk of a nuclear meltdown in Japan]]></description>
<content:encoded><![CDATA[Nuclear Concerns Prompt Buying. How long will it last? Mounting risk of a nuclear meltdown in Japan]]></content:encoded>
</item>
<item>
<title><![CDATA[Pfizer buys King Pharma for 3.6B  Transformational for PFE??]]></title>
<link>http://57thstresearch.wordpress.com/2010/10/12/pfizer-buys-king-pharma-for-3-6b-transformational-for-pfe/</link>
<pubDate>Tue, 12 Oct 2010 18:36:47 +0000</pubDate>
<dc:creator>Digital media and Analytics professional</dc:creator>
<guid>http://57thstresearch.wordpress.com/2010/10/12/pfizer-buys-king-pharma-for-3-6b-transformational-for-pfe/</guid>
<description><![CDATA[A 40% premium paid for king? Did Pfizer overpay? Pfizer Acquires Pain Drug Maker King for $3.6 Billi]]></description>
<content:encoded><![CDATA[A 40% premium paid for king? Did Pfizer overpay? Pfizer Acquires Pain Drug Maker King for $3.6 Billi]]></content:encoded>
</item>

</channel>
</rss>
